Cetuximab Response of Lung Cancer―Derived EGF Receptor Mutants Is Associated with Asymmetric DimerizationJEONGHEE CHO; LIANG CHEN; GREULICH, Heidi et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 22, pp 6770-6779, issn 0008-5472, 10 p.Article

EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung AdenocarcinomaMAI HE; CAPELLETTI, Marzia; JÄNNE, Pasi A et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1790-1797, issn 1078-0432, 8 p.Article

Novel mutant-selective EGFR kinase inhibitors against EGFR T790MWENJUN ZHOU; ERCAN, Dalia; ENGEN, John R et al.Nature (London). 2009, Vol 462, Num 7276, pp 1070-1074, issn 0028-0836, 5 p.Article

Structure and regulation of Src family kinasesBOGGON, Titus J; ECK, Michael J.Oncogene (Basingstoke). 2004, Vol 23, Num 48, pp 7918-7927, issn 0950-9232, 10 p.Article

EGFR mutation and resistance of non-small-cell lung cancer to gefitinibKOBAYASHI, Susumu; BOGGON, Titus J; DAYARAM, Tajhal et al.The New England journal of medicine. 2005, Vol 352, Num 8, pp 786-792, issn 0028-4793, 7 p.Article

Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog. CommentaryBOGGON, Titus J; YIQUN LI; MANLEY, Paul W et al.Blood. 2005, Vol 106, Num 3, pp 996-1002, issn 0006-4971, 8 p.Article

EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapyPAEZ, J. Guillermo; JÄNNE, Pasi A; NAOKI, Katsuhiko et al.Science (Washington, D.C.). 2004, Vol 304, Num 5676, pp 1497-1500, issn 0036-8075, 4 p.Article

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AMLJINGRUI JIANG; GUILLERMO PAEZ, J; FOX, Edward A et al.Blood. 2004, Vol 104, Num 6, pp 1855-1858, issn 0006-4971, 4 p.Article

A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8KIM, Peter W; SUN, Zhen-Yu J; BLACKLOW, Stephen C et al.Science (Washington, D.C.). 2003, Vol 301, Num 5640, pp 1725-1728, issn 0036-8075, 4 p.Article